Fewer Investors Than Expected Jumping On Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)
Jan 16
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedJan 18, 2025
DataAggregated Company Financials
Companies18
- 7D1.8%
- 3M-2.3%
- 1Y6.2%
- YTD3.7%
The Healthcare industry has stayed flat over the last week. The past year has been better, since the industry has gained 5.3% in that time. Earnings are forecast to grow by 11% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 18 Jan 2025 | €25.3b | €8.0b | €834.7m | 21.5x | 30.4x | 3.2x |
| Mon, 16 Dec 2024 | €24.5b | €19.0b | €1.4b | 18.7x | 17.1x | 1.3x |
| Wed, 13 Nov 2024 | €24.7b | €19.0b | €1.4b | 18.3x | 17.3x | 1.3x |
| Fri, 11 Oct 2024 | €25.2b | €18.9b | €1.4b | 17.3x | 18.3x | 1.3x |
| Sun, 08 Sep 2024 | €25.2b | €18.9b | €1.4b | 14.4x | 18.2x | 1.3x |
| Tue, 06 Aug 2024 | €24.7b | €18.9b | €1.4b | 16.1x | 17.8x | 1.3x |
| Thu, 04 Jul 2024 | €25.9b | €18.8b | €1.4b | 16.4x | 18.7x | 1.4x |
| Sat, 01 Jun 2024 | €26.1b | €18.8b | €1.4b | 17.5x | 18.8x | 1.4x |
| Mon, 29 Apr 2024 | €25.4b | €18.7b | €1.4b | 19.3x | 18.5x | 1.4x |
| Wed, 27 Mar 2024 | €25.8b | €18.6b | €1.4b | 21x | 18.5x | 1.4x |
| Fri, 23 Feb 2024 | €25.6b | €18.6b | €1.4b | 18.7x | 18.5x | 1.4x |
| Sun, 21 Jan 2024 | €24.1b | €18.6b | €1.4b | 18.5x | 17.3x | 1.3x |
| Tue, 19 Dec 2023 | €24.7b | €18.6b | €1.4b | 18.5x | 17.7x | 1.3x |
| Thu, 16 Nov 2023 | €22.9b | €18.6b | €1.4b | 16.9x | 16.5x | 1.2x |
| Sat, 14 Oct 2023 | €22.7b | €18.6b | €1.4b | 17.2x | 15.7x | 1.2x |
| Mon, 11 Sep 2023 | €23.4b | €17.3b | €1.1b | 15.2x | 20.5x | 1.4x |
| Wed, 09 Aug 2023 | €23.5b | €7.8b | €857.9m | 17.9x | 27.4x | 3x |
| Fri, 07 Jul 2023 | €23.0b | €7.7b | €822.5m | 16.8x | 28x | 3x |
| Sun, 04 Jun 2023 | €24.2b | €7.7b | €822.5m | 21.5x | 29.4x | 3.1x |
| Tue, 02 May 2023 | €24.0b | €7.6b | €826.9m | 21.9x | 29x | 3.2x |
| Thu, 30 Mar 2023 | €23.1b | €7.5b | €823.6m | 21.8x | 28.1x | 3.1x |
| Sat, 25 Feb 2023 | €23.3b | €7.5b | €867.3m | 24.2x | 26.8x | 3.1x |
| Mon, 23 Jan 2023 | €23.9b | €7.4b | €886.1m | 23.5x | 27x | 3.2x |
| Wed, 21 Dec 2022 | €23.2b | €7.4b | €886.1m | 21.9x | 26.2x | 3.1x |
| Fri, 18 Nov 2022 | €23.8b | €7.4b | €887.3m | 21.5x | 26.8x | 3.2x |
| Sun, 16 Oct 2022 | €21.8b | €7.3b | €908.8m | 19.1x | 24x | 3x |
| Tue, 13 Sep 2022 | €24.3b | €7.2b | €886.8m | 22.8x | 27.4x | 3.4x |
| Thu, 11 Aug 2022 | €25.8b | €7.1b | €900.2m | 23.2x | 28.6x | 3.6x |
| Sat, 09 Jul 2022 | €26.0b | €6.9b | €957.4m | 22x | 27.2x | 3.8x |
| Mon, 06 Jun 2022 | €24.4b | €6.9b | €957.8m | 20.8x | 25.5x | 3.5x |
| Wed, 04 May 2022 | €27.3b | €6.8b | €952.8m | 22.5x | 28.7x | 4x |
| Fri, 01 Apr 2022 | €29.8b | €6.7b | €951.9m | 24.4x | 31.3x | 4.4x |
| Sun, 27 Feb 2022 | €29.7b | €6.8b | €1.0b | 21.3x | 28.9x | 4.4x |
| Tue, 25 Jan 2022 | €31.5b | €6.8b | €1.0b | 21.1x | 30.7x | 4.6x |
Price to Earnings Ratio
30.7x
Current Industry PE
- Investors are optimistic on the Italian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 30.3x which is higher than its 3-year average PE of 23.4x.
- The 3-year average PS ratio of 2.5x is lower than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 6.6% per year over the last three years.
- Meanwhile revenues for these companies have grown 5.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 3.17% | |
| Healthcare | 1.84% | |
| Healthcare Services | 3.23% | |
| Pharma | 2.88% | |
| Biotech | -0.26% | |
| Medical Equipment | -0.58% | |
| Healthtech | -3.55% | |
| Life Sciences | -4.76% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 30.7%, which is lower than the prior year's growth of 672.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 42% over the next 5 years.
- However this is lower than its past earnings growth rate of 280% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 75% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| REC Recordati Industria Chimica e Farmaceutica | €54.90 | 2.9% +€316.9m | 10.3% | PE26.5x | |
| AMP Amplifon | €26.14 | 3.7% +€212.0m | -10.8% | PE37.8x | |
| ELN EL.En | €11.19 | 1.1% +€9.6m | 20.8% | PE17.5x | |
| IMD I.M.D. International Medical Devices | €1.50 | 4.9% +€1.2m | -14.0% | PE10.1x | |
| HI Health Italia | €137.00 | 1.5% +€374.0k | 24.5% | PE15.2x |
